1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp.
XNAS: RGEN

Repligen Corp Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vacc...

Read More
125.76 0.15 (0.12%)
28.45% Fall from 52W High
1.6M
XNAS Volume

XNAS 06 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Repligen Corp is on 15 May 2026 for the purpose of Repligen Corp Annual General Meeting for 2026 See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
35.7 / 100
Momentum Score
Technically Neutral
41.2 / 100
Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM
Analyst Price Target
180
1Yr Price target upside is 43%
18 analysts

10

S

11

W

5

O

0

T

SWOT Analysis

Repligen Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..